NISA INVESTMENT ADVISORS, LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 937615 ST. LOUIS, MO

Position in TEVA

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$680,073

+$254,628 QoQ

Shares Held

20,073

+42.1% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#369

of 674 holders

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NISA INVESTMENT ADVISORS, LLC holds $28,247,477 across 43 Drug Manufacturers - Specialty & Generic names. TEVA ranks #6 (2.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	138,149	$9,927,387
2	UTHR	UNITED THERAPEUTICS Corp	17,634	$9,554,630
3	VTRS	Viatris Inc	224,551	$3,565,869
4	LNTH	Lantheus Holdings, Inc.	7,166	$794,996
5	NBIX	Neurocrine Biosciences Inc	4,362	$735,171
6	TEVA	Teva Pharmaceutical Industries Ltd This page	20,073	$680,073
7	ELAN	Elanco Animal Health Inc	19,095	$469,927
8	BIOA	BioAge Labs, Inc.	11,977	$293,556

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$680,073	20,073	+42.1%	Shares	Sole	2026-08-10
2026-03-31	$425,445	14,125	+7.1%	Shares	Sole	2026-04-30
2025-12-31	$411,472	13,184	-17.0%	Shares	Sole	2026-01-15
2023-03-31	$140,626	15,890	+5.1%	Shares	Sole	2023-05-02
2022-12-31	$137,857	15,116	-41.5%	Shares	Sole	2023-02-02
2022-09-30	$208,431	25,828	-78.8%	Shares	Sole	2022-11-07
2022-06-30	$916,319	121,851	+41.9%	Shares	Sole	2022-08-03
2022-03-31	$806,441	85,883	-8.8%	Shares	Sole	2022-04-29
2021-12-31	$754,021	94,135	+303.3%	Shares	Sole	2022-02-03
2021-03-31	$269,343	23,340	-68.6%	Shares	Sole	2021-04-26
2020-06-30	$917,882	74,443	—	Shares	Sole	2020-07-27
No filing history on record for this holder in this stock.